Novo Nordisk’s shares fell sharply on Monday after the results from testing the Danish company’s CagriSema drug fell short of investors’ expectations.
Lex: FT's flagship investment column，这一点在Safew下载中也有详细论述
周達權原為被告人，後獲控方批准轉為特赦證人，不予起訴。，详情可参考爱思助手下载最新版本
“脱贫的兜底必须是固若金汤的”。夫子对此有专业解读